Muscle relaxants like cyclobenzaprine act primarily on the central nervous system by modulating gamma-aminobutyric acid (GABA) neurotransmission, which reduces muscle hyperactivity and neuronal hyperexcitability. In the context of Visual Snow Syndrome, these medications may help mitigate neurological symptoms by decreasing central nervous system overstimulation and potentially reducing aberrant sensory processing.